Background/Objectives: Cervical necrotizing fasciitis (CNF) is a rare but rapidly progressive deep-neck infection. Reports suggest a rising incidence after the COVID-19 pandemic, but host-response biomarkers remain poorly characterized. We evaluated whether the pandemic/post-pandemic era was associated with higher CNF frequency and a distinct immunonutritional profile. Methods: Retrospective cohort at a Croatian national tertiary referral center. Adults with CNF were grouped by admission era: pre-pandemic (2010–2019; n = 11; 10.00 years) and pandemic/post-pandemic (January 2021–April 2026; n = 15; 5.29 years). Incidence was compared by Poisson rate ratio (IRR). Admission biomarkers included classical indices (NLR, PLR, LMR, SII, AISI) and albumin-integrated composites (CAR, NAR, NPAR, PNI, CALLY, CAR/PNI, SIRI/albumin, AISI/albumin). Mann–Whitney U and Fisher’s exact tests were used with the Benjamini–Hochberg FDR correction; ROC analysis with bootstrap 95% CIs assessed era discrimination. Results: Incidence rose 2.6-fold (IRR = 2.58; 95% CI 1.18–5.61; p = 0.021); sensitivity analysis excluding 2026 was consistent (IRR = 2.36; p = 0.048). All 21 odontogenic cases originated from mandibular culprit teeth. Comorbidities (27% vs. 67%) and complications (27% vs. 53%) were more frequent in the pandemic/post-pandemic era, while overall mortality was 11.5%. Among the evaluated biomarkers, NPAR (q = 0.030) and CAR/PNI (q = 0.030) showed the strongest discriminatory performance for era classification (AUC 0.867 and 0.855, respectively) within this exploratory cohort. Streptococci fell from 82% to 33% (p = 0.021); S. pyogenes disappeared, S. anginosus/constellatus persisted, and atypical organisms (Acinetobacter, Candida, Corynebacterium) emerged exclusively post-pandemic (0% vs. 20%). Conclusions: Pandemic/post-pandemic CNF was more frequent, more comorbid, and biologically distinct, with a coherent hypoalbuminemic hyperinflammatory profile with diversified microbiology. In this single-center cohort, these associations are exploratory and hypothesis-generating, and the era label denotes a calendar period rather than a confirmed individual SARS-CoV-2 infection. NPAR and CAR/PNI emerged as the most promising exploratory biomarkers and warrant prospective multicenter validation.
No takes yet. Share an insight, caveat, or question.
Tarle et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: